BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 19620057)

  • 1. Effects of Splenectomy on Natural Killer Cell Levels in β-Thalassemia Major Patients.
    Kurtoğlu AU; Uğur S; Göçer M; Kurtoğlu E
    J Clin Lab Anal; 2024 May; 38(9):e25046. PubMed ID: 38814004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.
    Isgrò A; Marziali M; Sodani P; Gaziev J; Erer B; Polchi P; Paciaroni K; Roveda A; De Angelis G; Gallucci C; Alfieri C; Simone MD; Zinno F; Isacchi G; Adorno G; Lanti A; Leti W; Aiuti F; Fraboni D; Andreani M; Lucarelli G
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1557-66. PubMed ID: 20546907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
    Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
    Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
    Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.
    Bornhäuser M; Thiede C; Platzbecker U; Jenke A; Helwig A; Plettig R; Freiberg-Richter J; Röllig C; Geissler G; Lutterbeck K; Oelschlagel U; Ehninger G
    Clin Cancer Res; 2001 Aug; 7(8):2254-62. PubMed ID: 11489799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between cellular immune function during conditioning and graft rejection in patients with beta-thalassemia major].
    Hao WG; Huang SL; Sun X; Liu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1375-7. PubMed ID: 19620057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation.
    Locatelli F; Vinti L; Palumbo G; Rossi F; Bertaina A; Mastronuzzi A; Bernardo ME; Rutella S; Dellabona P; Giorgiani G; Moretta A; Moretta L
    Best Pract Res Clin Haematol; 2011 Sep; 24(3):339-49. PubMed ID: 21925087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation for thalassemia.
    Elborai Y; Uwumugambi A; Lehmann L
    Immunotherapy; 2012 Sep; 4(9):947-56. PubMed ID: 23046238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic cell transplantation for thalassemia: a global perspective BMT tandem meeting 2013.
    Mehta PA; Faulkner LB
    Biol Blood Marrow Transplant; 2013 Jan; 19(1 Suppl):S70-3. PubMed ID: 23110987
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.